Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

PVCT

Provectus Biopharmaceuticals, Inc.

USD

Set alert

Price alert · PVCT

All alert types
0.05 USD 0.00 0.00%
As of Oct 30, 2026
0.048 Day range 0.048
0.038 52-week range 0.072
YTD
-10.71%
1 year
-28.57%
Open
0.048
Prev close
0.05
Mkt cap
21.01M
Vol
20.50K
Avg vol
111.84K
EPS
-0.01
P/E
0.00
More statistics
Low
0.048
High
0.048

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for PVCT has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-264.75 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -4.3×
FY 2016: -0.2×FY 2017: -2.2×FY 2018: -2.3×FY 2019: -3.1×FY 2020: -2.9×FY 2021: -3.5×FY 2022: -12.7×FY 2023: -13.0×FY 2024: -10.6×FY 2025: -4.3×
FY 2016 5y median -10.6× FY 2025
P/S 69.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 45.9×FY 2023: 72.2×FY 2024: 81.7×FY 2025: 69.9×
FY 2016 5y median 69.9× FY 2025
P/B -3.7×
FY 2016: 1.3×FY 2017: -3.0×FY 2018: -1.1×FY 2019: -1.0×FY 2020: -0.8×FY 2021: -5.4×FY 2022: -7.3×FY 2023: -5.3×FY 2024: -8.5×FY 2025: -3.7×
FY 2016 5y median -5.4× FY 2025
P/FCF -7.1×
FY 2016: -0.2×FY 2017: -2.9×FY 2018: -3.7×FY 2019: -3.9×FY 2020: -5.6×FY 2021: -22.2×FY 2022: -14.9×FY 2023: -15.7×FY 2024: -15.4×FY 2025: -7.1×
FY 2016 5y median -15.4× FY 2025
EV/EBITDA -5.4×
FY 2016: -0.1×FY 2017: -3.1×FY 2018: -4.5×FY 2019: -8.1×FY 2020: -9.9×FY 2021: -5.1×FY 2022: -13.9×FY 2023: -14.9×FY 2024: -11.8×FY 2025: -5.4×
FY 2016 5y median -11.8× FY 2025
EV/Sales 78.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 48.2×FY 2023: 77.5×FY 2024: 86.4×FY 2025: 78.0×
FY 2016 5y median 77.5× FY 2025
FCF Yield -14.2%
FY 2016: -469.0%FY 2017: -34.3%FY 2018: -27.2%FY 2019: -25.4%FY 2020: -17.9%FY 2021: -4.5%FY 2022: -6.7%FY 2023: -6.4%FY 2024: -6.5%FY 2025: -14.2%
FY 2016 5y median -6.5% FY 2025

Profitability

Gross Margin 99.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 93.6%FY 2023: -204.8%FY 2024: 98.8%FY 2025: 99.4%
FY 2016 5y median 93.6% FY 2025
Operating Margin -1441.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -346.6%FY 2023: -520.2%FY 2024: -640.8%FY 2025: -1441.3%
FY 2016 5y median -520.2% FY 2025
Net Margin -1615.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -359.3%FY 2023: -556.2%FY 2024: -766.9%FY 2025: -1615.8%
FY 2016 5y median -556.2% FY 2025
ROE 86.2%
FY 2016: -704.1%FY 2017: 134.9%FY 2018: 46.8%FY 2019: 28.8%FY 2020: 22.1%FY 2021: 132.3%FY 2022: 57.1%FY 2023: 40.9%FY 2024: 79.4%FY 2025: 86.2%
FY 2016 5y median 79.4% FY 2025
ROIC 145.7%
FY 2016: -701.6%FY 2017: 2364.4%FY 2018: 340.6%FY 2019: 705.4%FY 2020: 77.4%FY 2021: 194.9%FY 2022: 85.7%FY 2023: 63.2%FY 2024: 141.7%FY 2025: 145.7%
FY 2016 5y median 141.7% FY 2025
ROA -778.6%
FY 2016: -435.3%FY 2017: -393.4%FY 2018: -410.1%FY 2019: -468.8%FY 2020: -1133.4%FY 2021: -157.7%FY 2022: -174.5%FY 2023: -214.1%FY 2024: -470.4%FY 2025: -778.6%
FY 2016 5y median -214.1% FY 2025

Growth (YoY)

Revenue -45.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -43.6%FY 2024: 10.7%FY 2025: -45.5%
FY 2016 FY 2025
Operating Income -22.5%
FY 2016: 0.6%FY 2017: 44.0%FY 2018: 41.6%FY 2019: 21.3%FY 2020: 21.2%FY 2021: 5.9%FY 2022: 26.6%FY 2023: 15.4%FY 2024: -36.3%FY 2025: -22.5%
FY 2016 FY 2025
EPS (diluted) -14.2%
FY 2016: 23.1%FY 2017: 63.4%FY 2018: 41.8%FY 2019: 6.1%FY 2020: 0.0%FY 2021: 20.5%FY 2022: 46.5%FY 2023: 12.9%FY 2024: -52.7%FY 2025: -14.2%
FY 2016 FY 2025
Free Cash Flow -1.3%
FY 2016: -26.0%FY 2017: 52.7%FY 2018: 49.9%FY 2019: -18.9%FY 2020: 34.0%FY 2021: 75.2%FY 2022: -200.2%FY 2023: 15.4%FY 2024: -27.7%FY 2025: -1.3%
FY 2016 FY 2025

Financial Health

Current Ratio 0.1×
FY 2016: 0.9×FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.0×FY 2021: 0.4×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Quick Ratio 0.1×
FY 2016: 0.9×FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.0×FY 2021: 0.4×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Debt / Equity -0.5×
FY 2016: 0.0×FY 2017: -0.9×FY 2018: -0.8×FY 2019: -0.8×FY 2020: -0.8×FY 2021: -0.4×FY 2022: -0.4×FY 2023: -0.4×FY 2024: -0.5×FY 2025: -0.5×
FY 2016 5y median -0.4× FY 2025
Net Debt / EBITDA -0.6×
FY 2016: 0.0×FY 2017: -0.7×FY 2018: -1.9×FY 2019: -3.6×FY 2020: -5.0×FY 2021: -0.2×FY 2022: -0.6×FY 2023: -1.0×FY 2024: -0.6×FY 2025: -0.6×
FY 2016 5y median -0.6× FY 2025
Interest Coverage -23.0×
FY 2016: 0.0×FY 2017: -37.1×FY 2018: -8.3×FY 2019: -4.3×FY 2020: -2.8×FY 2021: -4.9×FY 2022: -20.9×FY 2023: -13.4×FY 2024: -16.5×FY 2025: -23.0×
FY 2016 5y median -16.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 43741.5%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -8375.1%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31